DVA DaVita Inc.
Healthcare$198.52-0.07%ClosedMarket Cap: $12.74B
As of 2026-05-25
Valuation
P/E (TTM)
13.43
PEG
—
P/B
-17.71
P/S
0.92
EV/EBITDA
9.35
DCF Value
$256.60
FCF Yield
11.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
31.1%
Operating Margin
15.0%
Net Margin
5.6%
ROE
-133.1%
ROA
4.5%
ROIC
10.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.42B | 31.4% | $481.9M | $197.5M | $— | — |
| Q4 null | $3.62B | 28.3% | $551.2M | $234.2M | $— | — |
| FY null | $13.64B | 27.0% | $2.01B | $746.8M | $— | — |
| Q3 null | $3.42B | 31.8% | $505.8M | $150.3M | $— | — |
| Q2 null | $3.38B | 33.1% | $537.8M | $199.3M | $— | — |
| Q1 null | $3.22B | 30.5% | $438.9M | $162.9M | $— | — |
| Q4 null | $3.29B | 32.5% | $565.4M | $259.3M | $— | — |
| FY null | $12.82B | 32.9% | $2.09B | $936.3M | $— | — |
| Q3 null | $3.26B | 34.1% | $534.9M | $214.7M | $— | — |
| Q2 null | $3.19B | 32.8% | $506.4M | $222.7M | $— | — |
| Q1 null | $3.07B | 32.3% | $483.8M | $239.6M | $— | — |
| Q4 2023 | $3.15B | 32.0% | $389.9M | $150.7M | $1.62 | — |